Acenocoumarol After CABG
Clinical studies have investigated the role of oral anticoagulants including acenocoumarol in preventing occlusion of the venous grafts in patients who have undergone a coronary artery bypass grafting (CABG). These studies have shown that the oral anticoagulants including acenocoumarol are effective in preventing reocclusion of the graft.
Studies in post-CABG patients
|Investigators & study design||Patients||Drug treatment||Results|
| Mulder et al.58
Prospective, randomized multicentre study
|127 patients who have undergone CABG with venous grafts||
*Prevention of Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study